Creative Planning Boosts Holdings in Amedisys, Inc. (NASDAQ:AMED)

Creative Planning boosted its position in Amedisys, Inc. (NASDAQ:AMED) by 12.6% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,838 shares of the health services provider’s stock after buying an additional 543 shares during the period. Creative Planning’s holdings in Amedisys were worth $467,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of AMED. Exchange Traded Concepts LLC boosted its position in shares of Amedisys by 6.4% during the 3rd quarter. Exchange Traded Concepts LLC now owns 7,508 shares of the health services provider’s stock worth $725,000 after purchasing an additional 450 shares in the last quarter. Inspire Investing LLC boosted its position in shares of Amedisys by 11.2% during the 3rd quarter. Inspire Investing LLC now owns 4,250 shares of the health services provider’s stock worth $410,000 after purchasing an additional 428 shares in the last quarter. CWM LLC boosted its position in shares of Amedisys by 14.5% during the 3rd quarter. CWM LLC now owns 2,190 shares of the health services provider’s stock worth $211,000 after purchasing an additional 277 shares in the last quarter. SG Americas Securities LLC boosted its position in shares of Amedisys by 413.4% during the 3rd quarter. SG Americas Securities LLC now owns 196,713 shares of the health services provider’s stock worth $18,985,000 after purchasing an additional 158,398 shares in the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund boosted its position in shares of Amedisys by 2,159.1% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 27,200 shares of the health services provider’s stock worth $2,497,000 after purchasing an additional 25,996 shares in the last quarter. 94.36% of the stock is currently owned by hedge funds and other institutional investors.

Amedisys Price Performance

Amedisys stock opened at $97.71 on Thursday. Amedisys, Inc. has a 52 week low of $89.55 and a 52 week high of $98.95. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.30. The firm’s 50-day simple moving average is $96.75 and its 200 day simple moving average is $95.76. The firm has a market capitalization of $3.20 billion, a PE ratio of 34.90, a P/E/G ratio of 1.87 and a beta of 0.78.

Analyst Ratings Changes

Several equities research analysts have commented on the stock. Deutsche Bank Aktiengesellschaft lowered shares of Amedisys from a “buy” rating to a “hold” rating and set a $101.00 target price on the stock. in a research report on Monday, July 29th. Cantor Fitzgerald restated a “neutral” rating and set a $101.00 target price on shares of Amedisys in a research report on Thursday, July 25th. Four research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, Amedisys presently has an average rating of “Hold” and an average target price of $100.67.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.